Journal of the National Cancer Institute Advance Access originally published online on April 8, 2008
JNCI Journal of the National Cancer Institute 2008 100(8):596; doi:10.1093/jnci/djn078
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press.
CORRESPONDENCE |
Re: Breast Cancer Incidence, 1980–2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status
Affiliations of authors: Department of Preventive Medicine and Biometrics, University of Colorado School of Medicine, Denver, CO (TB, ST); Department of Biology, University of Colorado, Colorado Springs, CO (LH)
Correspondence to: Tim Byers, MD, MPH, Department of Preventive Medicine and Biometrics, University of Colorado School of Medicine, PO Box 6508, Aurora, CO 80045 (e-mail: tim.byers@uchsc.edu).
| The first 10% of the full text of this article appears below. |
Glass et al. (1) reported on the trends in breast cancer incidence between 1980 and 2006 by estrogen receptor (ER) status among women in the Kaiser Permanente Northwest health-care system. Their discussion about the rise (from 1980 to 2000) and subsequent fall (from 2000 to 2006) in ER-positive breast cancer incidence was a